Article
GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism.
BioMed research international - 1 Jan 2022
Wan Ping, Hou Yuchen, Qiu Bijun, Feng Mingxuan, Yang Taihua, Luo Yi, Xia Lei, Chen Xiaosong, Zhang Jianjun, Xue Feng, Xia Qiang
Abstract excerpt
Objectives: Tacrolimus is characterized by high pharmacokinetic variability in combination with a narrow therapeutic range. However, influence of donor CYP3A5 genotype and graft-to-recipient body weight ratio (GRWR) on tacrolimus' pharmacokinetics after pediatric living donor liver transplantation (LDLT) remains unclear. Methods: A total of 174 LDLT recipients (<6 y) were grouped according to donor CYP3A5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
